A novel live cell diagnostic platform measuring phenotypic biomarkers using objective algorithmic analysis enables further risk stratification for intermediate-risk prostate cancer patients

被引：0
|
作者：
Manak, Michael S. [1 ]
Su, Wendell R. [1 ]
Min, Andrew [1 ]
Hogan, Brad J. [1 ]
Whitfield, Matthew J. [1 ]
Varsanik, Jonathan S. [1 ]
Bergen, Delaney [1 ]
Foroohar, Mani [1 ]
Rieger-Christ, Kimberly M. [2 ]
Sullivan, Travis B. [2 ]
Kella, Naveen [3 ]
Hernandez, Ray [3 ]
Mouraviev, Vladimir [4 ]
Knopf, Kevin B. [5 ]
Rashid, Hani H. [6 ]
Albala, David M. [4 ]
Sant, Grannum R. [7 ]
Chander, Ashok C. [1 ]
机构：
[1] Cellanyx Diagnost, Beverly, MA USA
[2] Lahey Hosp & Med Ctr, Burlington, MA USA
[3] Urol & Prostate Inst, San Antonio, TX USA
[4] Associated Med Profess New York, Syracuse, NY USA
[5] Calif Pacific Med Ctr, San Francisco, CA USA
[6] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA
[7] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4347
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4347
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A NOVEL LIVE CELL MICROFLUIDIC DIAGNOSTIC USING PHENOTYPIC BIOMARKERS WITH OBJECTIVE ALGORITHMIC ANALYSIS FOR PROSTATE CANCER RISK STRATIFICATION.
    Rieger-Christ, Kimberly
    Sullivan, Travis
    Kella, Naveen
    Hernandez, Ray
    Mouraviev, Vladimir
    Knopf, Kevin
    Rashid, Hani
    Manak, Michael
    Su, Wendell
    Hogan, Brad
    Min, Andrew
    Berger, Delaney
    Whitfield, Matthew
    Varsanik, Jonathan
    Foroohar, Mani
    Chander, Ashok
    Albala, David
    Sant, Grannum
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E8 - E9
  • [2] A novel live cell microfluidic diagnostic using phenotypic biomarkers with objective algorithmic analysis for genitourinary cancer risk stratification
    Sant, G.
    Rieger-Christ, K.
    Kella, N.
    Mouraviev, V.
    Knopf, K. B.
    Rashid, H. H.
    Manak, M. S.
    Hogan, B. J.
    Varsanik, J. S.
    Foroohar, M.
    Chander, A. C.
    Albala, D. M.
    [J]. BJU INTERNATIONAL, 2016, 117 : 4 - 4
  • [3] Stratification of patients with intermediate-risk prostate cancer
    Jung, Jin-Woo
    Lee, Jung Keun
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    [J]. BJU INTERNATIONAL, 2015, 115 (06) : 907 - 912
  • [4] Improving the Stratification of Patients With Intermediate-risk Prostate Cancer
    Stolzenbach, Lara Franziska
    Nocera, Luigi
    Colla-Ruvolo, Claudia
    Tian, Zhe
    Knipper, Sophie
    Maurer, Tobias
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (02) : E120 - E128
  • [5] Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer
    Moschini, Marco
    Gandaglia, Giorgio
    Suardi, Nazareno
    Fossati, Nicola
    Cucchiara, Vito
    Damiano, Rocco
    Cantiello, Francesco
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Briganti, Alberto
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 555 - 561
  • [6] Proteomic-based stratification of intermediate-risk prostate cancer patients
    Zhong, Qing
    Sun, Rui
    Aref, Adel
    Noor, Zainab
    Anees, Asim
    Zhu, Yi
    Lucas, Natasha
    Poulos, Rebecca C.
    Lyu, Mengge
    Zhu, Tiansheng
    Chen, Guo-Bo
    Wang, Yingrui
    Ding, Xuan
    Rutishauser, Dorothea
    Rupp, Niels J.
    Rueschoff, Jan H.
    Poyet, Cedric
    Hermanns, Thomas
    Fankhauser, Christian
    Martinez, Maria Rodriguez
    Shao, Wenguang
    Buljan, Marija
    Neumann, Janis Frederick
    Beyer, Andreas
    Hains, Peter G.
    Reddel, Roger R.
    Robinson, Phillip J.
    Aebersold, Ruedi
    Guo, Tiannan
    Wild, Peter J.
    [J]. LIFE SCIENCE ALLIANCE, 2024, 7 (02)
  • [7] A novel live cell platform diagnostic utilizing phenotypic biomarkers for assessing prostate cancer aggressiveness.
    Knope, Kevin B.
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Kella, Naveen
    Rashid, Hani H.
    Mouraviev, Vladimir
    Manak, Michael S.
    Hogan, Brad J.
    Dixlt, Gauri
    Su, Wendell R.
    Berger, Delaney
    Whitfield, Matthew J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Zappala, Stephen M.
    Albala, David
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Editorial Comment to Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer
    Yashi, Masahiro
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 561 - 562
  • [9] COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS
    Zubek, V. B.
    Khan, F.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A41 - A41
  • [10] Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
    Merrick, Gregory S.
    Butler, Wayne M.
    Galbreath, Robert W.
    Fiano, Ryan
    Adamovich, Edward
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2015, 7 (06) : 430 - 436
12345